Janus Henderson Group’s Larimar Therapeutics LRMR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-5,571,963
| Closed | -$13.1M | – | 2468 |
|
|
2025
Q1 | $13.1M | Sell |
5,571,963
-871,323
| -14% | -$2.04M | 0.01% | 657 |
|
|
2024
Q4 | $24.9M | Buy |
6,443,286
+876,431
| +16% | +$3.39M | 0.01% | 533 |
|
|
2024
Q3 | $36.4M | Buy |
5,566,855
+1,189,467
| +27% | +$7.77M | 0.02% | 454 |
|
|
2024
Q2 | $31.6M | Buy |
4,377,388
+356,423
| +9% | +$2.58M | 0.02% | 483 |
|
|
2024
Q1 | $30.5M | Buy |
4,020,965
+1,379,900
| +52% | +$10.5M | 0.02% | 486 |
|
|
2023
Q4 | $12M | Buy |
2,641,065
+179,603
| +7% | +$819K | 0.01% | 634 |
|
|
2023
Q3 | $9.71M | Buy |
2,461,462
+1,015,736
| +70% | +$4.01M | 0.01% | 670 |
|
|
2023
Q2 | $4.53M | Buy |
1,445,726
+375,295
| +35% | +$1.18M | ﹤0.01% | 888 |
|
|
2023
Q1 | $4.86M | Buy |
1,070,431
+143,162
| +15% | +$650K | ﹤0.01% | 882 |
|
|
2022
Q4 | $3.82M | Sell |
927,269
-672,731
| -42% | -$2.77M | ﹤0.01% | 920 |
|
|
2022
Q3 | $5.14M | Buy |
1,600,000
+850,932
| +114% | +$2.74M | ﹤0.01% | 989 |
|
|
2022
Q2 | $1.48M | Sell |
749,068
-296,177
| -28% | -$586K | ﹤0.01% | 1152 |
|
|
2022
Q1 | $4.22M | Buy |
1,045,245
+310,133
| +42% | +$1.25M | ﹤0.01% | 1047 |
|
|
2021
Q4 | $7.92M | Buy |
735,112
+93,997
| +15% | +$1.01M | ﹤0.01% | 951 |
|
|
2021
Q3 | $7.46M | Buy |
641,115
+40,155
| +7% | +$467K | ﹤0.01% | 960 |
|
|
2021
Q2 | $5.89M | Buy |
600,960
+458,613
| +322% | +$4.49M | ﹤0.01% | 1031 |
|
|
2021
Q1 | $2.08M | Buy |
142,347
+3,602
| +3% | +$52.6K | ﹤0.01% | 1183 |
|
|
2020
Q4 | $2.97M | Sell |
138,745
-24,854
| -15% | -$531K | ﹤0.01% | 1063 |
|
|
2020
Q3 | $2.54M | Buy |
+163,599
| New | +$2.54M | ﹤0.01% | 1020 |
|